rabv glycoprotein Search Results


93
Sino Biological trimeric rabv g
Trimeric Rabv G, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabv+glycoprotein/Rabies+virus+(RABV)+Glycoprotein%2FG+Protein/pm41274418-121-19-21
Average 93 stars, based on 1 article reviews
trimeric rabv g - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier


90
CureVac Inc rabies virus glycoprotein (rabv-g)
Current clinical trials of LNP@mRNA.
Rabies Virus Glycoprotein (Rabv G), supplied by CureVac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabv+glycoprotein/rabies+virus+glycoprotein++rabv+g++lnp/pmc09787894-45-6-0
Average 90 stars, based on 1 article reviews
rabies virus glycoprotein (rabv-g) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CureVac Inc sequence-optimized, chemically unmodified mrna encoding the rabies virus glycoprotein (rabv-g)
<t>Proposed</t> <t>sequence</t> of events leading to the generation of adaptive immune responses upon <t>mRNA</t> vaccination. Local inflammation at the injection site promotes the infiltration of immune cells, including neutrophils, monocytes, myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs). Neutrophils can efficiently take up LNPs, but monocytes and MDCs translate mRNA more efficiently. Secretion of type I interferons (IFNs) is stimulated. mRNA/LNP and protein antigen will disseminate and cells will migrate to the vaccine-draining lymph nodes. Antigen presentation to T cells and interactions of antigen and B cells take place at these sites. This leads to the formation of germinal centers, which results in the generation of memory B cells and antibody-producing plasma cells that reside to the bone marrow. The basic illustration was made by Elizabeth Thompson and some elements were created using BioRender.com .
Sequence Optimized, Chemically Unmodified Mrna Encoding The Rabies Virus Glycoprotein (Rabv G), supplied by CureVac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabv+glycoprotein/sequence+optimized++chemically+unmodified+mrna+encoding+the+rabies+virus+glycoprotein++rabv+g+/pmc07831080-87-31-21
Average 90 stars, based on 1 article reviews
sequence-optimized, chemically unmodified mrna encoding the rabies virus glycoprotein (rabv-g) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CureVac Inc mrna rnactive, protamine i.d. rabies virus glycoprotein (rabv-g)
<t>Proposed</t> <t>sequence</t> of events leading to the generation of adaptive immune responses upon <t>mRNA</t> vaccination. Local inflammation at the injection site promotes the infiltration of immune cells, including neutrophils, monocytes, myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs). Neutrophils can efficiently take up LNPs, but monocytes and MDCs translate mRNA more efficiently. Secretion of type I interferons (IFNs) is stimulated. mRNA/LNP and protein antigen will disseminate and cells will migrate to the vaccine-draining lymph nodes. Antigen presentation to T cells and interactions of antigen and B cells take place at these sites. This leads to the formation of germinal centers, which results in the generation of memory B cells and antibody-producing plasma cells that reside to the bone marrow. The basic illustration was made by Elizabeth Thompson and some elements were created using BioRender.com .
Mrna Rnactive, Protamine I.D. Rabies Virus Glycoprotein (Rabv G), supplied by CureVac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabv+glycoprotein/mrna+rnactive++protamine+i+d++rabies+virus+glycoprotein++rabv+g+/pmc06453548-335-27-23
Average 90 stars, based on 1 article reviews
mrna rnactive, protamine i.d. rabies virus glycoprotein (rabv-g) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

N/A
Mouse anti Rabies Virus Glycoprotein antibody, clone 2D6 recognizes the glycoprotein of rabies virus, a Lyssavirus that causes rabies in mammals. Mouse anti Rabies Virus Glycoprotein antibody, clone 2D6 recognizes the purified glycoprotein of the
  Buy from Supplier

N/A
A DNA sequence encoding the Rabies virus (RABV) (strain CTN-1) Glycoprotein/G (FJ959397.1) was expressed with a C-terminal polyhistidine tag.
  Buy from Supplier

N/A
Reacts with glycoprotein from Rabies virus. Cross reactivity with glycoprotein from other Rhabdoviruses not tested. PurificationStore at 4 oC; DO NOT FREEZE; Stable for 6 months from the date of shipment. Non-hazardous.http://www.creative-diagnostics.com/Anti-Ectodomain-of-Glycoprotein-Rabies-Virus-Antibody-54157-147.htm
  Buy from Supplier



N/A
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Rabies virus (RABV) Glycoprotein/G (Catalog# 40997-VNAH3). The IgG fraction
  Buy from Supplier

N/A
Shipped at 4°C. Upon delivery aliquot and store at-20°C. Avoid freeze / thaw cycles.http://www.creative-diagnostics.com/Anti-Rabies-Virus-Glycoprotein-Antibody-130456-144.htm
  Buy from Supplier

Image Search Results


Current clinical trials of LNP@mRNA.

Journal: Pharmaceutics

Article Title: Recent Advances in Lipid Nanoparticles for Delivery of mRNA

doi: 10.3390/pharmaceutics14122682

Figure Lengend Snippet: Current clinical trials of LNP@mRNA.

Article Snippet: CureVac , CV7202 , Rabies , Rabies virus glycoprotein (RABV-G) , i.m. , LNP , NCT03713086 (I).

Techniques: Clinical Proteomics, Plasmid Preparation, Infection, Virus, Membrane, Injection

Proposed sequence of events leading to the generation of adaptive immune responses upon mRNA vaccination. Local inflammation at the injection site promotes the infiltration of immune cells, including neutrophils, monocytes, myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs). Neutrophils can efficiently take up LNPs, but monocytes and MDCs translate mRNA more efficiently. Secretion of type I interferons (IFNs) is stimulated. mRNA/LNP and protein antigen will disseminate and cells will migrate to the vaccine-draining lymph nodes. Antigen presentation to T cells and interactions of antigen and B cells take place at these sites. This leads to the formation of germinal centers, which results in the generation of memory B cells and antibody-producing plasma cells that reside to the bone marrow. The basic illustration was made by Elizabeth Thompson and some elements were created using BioRender.com .

Journal: Vaccines

Article Title: Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

doi: 10.3390/vaccines9010061

Figure Lengend Snippet: Proposed sequence of events leading to the generation of adaptive immune responses upon mRNA vaccination. Local inflammation at the injection site promotes the infiltration of immune cells, including neutrophils, monocytes, myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs). Neutrophils can efficiently take up LNPs, but monocytes and MDCs translate mRNA more efficiently. Secretion of type I interferons (IFNs) is stimulated. mRNA/LNP and protein antigen will disseminate and cells will migrate to the vaccine-draining lymph nodes. Antigen presentation to T cells and interactions of antigen and B cells take place at these sites. This leads to the formation of germinal centers, which results in the generation of memory B cells and antibody-producing plasma cells that reside to the bone marrow. The basic illustration was made by Elizabeth Thompson and some elements were created using BioRender.com .

Article Snippet: One of the early-generation mRNA vaccines that has been extensively studied was developed by one of the largest mRNA vaccine companies, CureVac AG (Tübingen, Germany), and was based on sequence-optimized, chemically unmodified mRNA encoding the rabies virus glycoprotein (RABV-G).

Techniques: Sequencing, Injection